BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roushandeh AM, Bahadori M, Roudkenar MH. Mesenchymal Stem Cell-based Therapy as a New Horizon for Kidney Injuries. Arch Med Res 2017;48:133-46. [PMID: 28625316 DOI: 10.1016/j.arcmed.2017.03.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Yaron JR, Kwiecien JM, Zhang L, Ambadapadi S, Wakefield DN, Clapp WL, Dabrowski W, Burgin M, Munk BH, Mcfadden G, Chen H, Lucas AR. Modifying the Organ Matrix Pre-engraftment: A New Transplant Paradigm? Trends in Molecular Medicine 2019;25:626-39. [DOI: 10.1016/j.molmed.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nasiri E, Alizadeh A, Roushandeh AM, Gazor R, Hashemi-firouzi N, Golipoor Z. Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease. Metab Brain Dis 2019;34:1131-43. [DOI: 10.1007/s11011-019-00421-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
3 Uchida N, Kumagai N, Kondo Y. Application of Muse Cell Therapy for Kidney Diseases. Adv Exp Med Biol 2018;1103:199-218. [PMID: 30484231 DOI: 10.1007/978-4-431-56847-6_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Eirin A, Lerman LO. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet? Hypertension 2021;78:261-9. [PMID: 34176287 DOI: 10.1161/HYPERTENSIONAHA.121.14596] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Payandeh Z, Pirpour Tazehkand A, Azargoonjahromi A, Almasi F, Alagheband Bahrami A. The Role of Cell Organelles in Rheumatoid Arthritis with Focus on Exosomes. Biol Proced Online 2021;23:20. [PMID: 34736402 DOI: 10.1186/s12575-021-00158-4] [Reference Citation Analysis]
6 Nahand JS, Mahjoubin-Tehran M, Moghoofei M, Pourhanifeh MH, Mirzaei HR, Asemi Z, Khatami A, Bokharaei-Salim F, Mirzaei H, Hamblin MR. Exosomal miRNAs: novel players in viral infection. Epigenomics 2020;12:353-70. [PMID: 32093516 DOI: 10.2217/epi-2019-0192] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
7 Asgarpour K, Shojaei Z, Amiri F, Ai J, Mahjoubin-Tehran M, Ghasemi F, ArefNezhad R, Hamblin MR, Mirzaei H. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages. Cell Commun Signal 2020;18:149. [PMID: 32917227 DOI: 10.1186/s12964-020-00650-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
8 Bashiri H, Amiri F, Hosseini A, Hamidi M, Mohammadi Roushandeh A, Kuwahara Y, Jalili MA, Habibi Roudkenar M. Dual Preconditioning: A Novel Strategy to Withstand Mesenchymal Stem Cells against Harsh Microenvironments. Adv Pharm Bull. 2018;8:465-470. [PMID: 30276143 DOI: 10.15171/apb.2018.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
9 Carter NJ, Roach ZA, Byrnes MM, Zhu Y. Adamts9 is necessary for ovarian development in zebrafish. Gen Comp Endocrinol 2019;277:130-40. [PMID: 30951722 DOI: 10.1016/j.ygcen.2019.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
10 Nam Y, Rim YA, Lee J, Ju JH. Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration. Stem Cells Int 2018;2018:8490489. [PMID: 29765426 DOI: 10.1155/2018/8490489] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
11 Atia MM, Alghriany AAI. Adipose-derived mesenchymal stem cells rescue rat hippocampal cells from aluminum oxide nanoparticle-induced apoptosis via regulation of P53, Aβ, SOX2, OCT4, and CYP2E1. Toxicol Rep 2021;8:1156-68. [PMID: 34150525 DOI: 10.1016/j.toxrep.2021.06.003] [Reference Citation Analysis]
12 Sherif IO, Sabry D, Abdel-Aziz A, Sarhan OM. The role of mesenchymal stem cells in chemotherapy-induced gonadotoxicity. Stem Cell Res Ther 2018;9:196. [PMID: 30021657 DOI: 10.1186/s13287-018-0946-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zhou S, Liu YG, Zhang Y, Hu JM, Liu D, Chen H, Li M, Guo Y, Fan LP, Li LY, Zhao M. Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats. J Cell Biochem 2018;119:8220-32. [PMID: 29932236 DOI: 10.1002/jcb.26833] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Najafi-Ghalehlou N, Roudkenar MH, Langerodi HZ, Roushandeh AM. Taming of Covid-19: potential and emerging application of mesenchymal stem cells. Cytotechnology 2021;:1-46. [PMID: 33776206 DOI: 10.1007/s10616-021-00461-8] [Reference Citation Analysis]
15 Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65-76. [PMID: 29229532 DOI: 10.1016/j.ejphar.2017.12.016] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 17.8] [Reference Citation Analysis]
16 Rad F, Ghorbani M, Mohammadi Roushandeh A, Habibi Roudkenar M. Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles. Mol Biol Rep. 2019;46:1533-1549. [PMID: 30623280 DOI: 10.1007/s11033-019-04588-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
17 Wang LJ, Yan CP, Chen D, Xu T, He S, Zhang H, Xu C, Qiao Y, Jiang ZY, Zhang RP, Li JD. Efficacy Evaluation and Tracking of Bone Marrow Stromal Stem Cells in a Rat Model of Renal Ischemia-Reperfusion Injury. Biomed Res Int 2019;2019:9105768. [PMID: 31016203 DOI: 10.1155/2019/9105768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Zhou S, Qiao YM, Liu YG, Liu D, Hu JM, Liao J, Li M, Guo Y, Fan LP, Li LY, Zhao M. Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury. Cell Biosci. 2020;10:130. [PMID: 33292452 DOI: 10.1186/s13578-020-00492-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Fazeli Z, Esmaeilizadeh Z, Omrani MD, Ghaderian SMH, Rajabibazl M. HEK293-Conditioned Medium Altered the Expression of Renal Markers WT1, CD2AP, and CDH16 in the Human Adipose Mesenchymal Stem Cells. Regen Eng Transl Med . [DOI: 10.1007/s40883-021-00246-7] [Reference Citation Analysis]
20 AbdRabou MA, Mehany ABM, Farrag IM, Belal A, Abdelzaher OF, El-Sharkawy A, Abd El-Azez AM, El-Sharkawy SM, Al Badawi MH. Therapeutic Effect of Murine Bone Marrow-Derived Mesenchymal Stromal/Stem Cells and Human Placental Extract on Testicular Toxicity Resulting from Doxorubicin in Rats. Biomed Res Int 2021;2021:9979670. [PMID: 34409109 DOI: 10.1155/2021/9979670] [Reference Citation Analysis]
21 Chung BH. Use of mesenchymal stem cells for chronic kidney disease. Kidney Res Clin Pract 2019;38:131-4. [PMID: 31189218 DOI: 10.23876/j.krcp.19.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
22 Wei JJ, Tang L, Chen LL, Xie ZH, Ren Y, Qi HG, Lou JY, Weng GB, Zhang SW. Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells. Iran J Public Health 2021;50:908-18. [PMID: 34183949 DOI: 10.18502/ijph.v50i5.6108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ramírez-Bajo MJ, Martín-Ramírez J, Bruno S, Pasquino C, Banon-Maneus E, Rovira J, Moya-Rull D, Lazo-Rodriguez M, Campistol JM, Camussi G, Diekmann F. Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity. Front Cell Dev Biol 2020;8:296. [PMID: 32432111 DOI: 10.3389/fcell.2020.00296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Abbasi-malati Z, Roushandeh AM, Kuwahara Y, Roudkenar MH. Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents. Stem Cell Rev and Rep 2018;14:484-99. [DOI: 10.1007/s12015-018-9817-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
25 Roushandeh AM, Kuwahara Y, Roudkenar MH. Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases. Cytotechnology 2019;71:647-63. [PMID: 30706303 DOI: 10.1007/s10616-019-00302-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
26 Grange C, Iampietro C, Bussolati B. Stem cell extracellular vesicles and kidney injury. Stem Cell Investig 2017;4:90. [PMID: 29270416 DOI: 10.21037/sci.2017.11.02] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]